Home > Products > API > Remogliflozin etabonate
Remogliflozin etabonate
  • Remogliflozin etabonateRemogliflozin etabonate

Remogliflozin etabonate

Product Name: Remogliflozin etabonate
Formulae hypotheticae: C26H38N2O9
Molecular pondus; 522.6 "
CAS Subcriptio Number; 442201-24-3

Model:CAS NO:442201-24-3

Mitte Inquisitionem

depictio producti

Remogliflozin etabonate

Product nomen:Remogliflozin etabonate  442201-24-3
CAS No:442201-24-3
Specification: in domo

Nomen Remogliflozin etabonate
Synonyma ReMogliflozinetabonate;ethyl[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[5-methyl-1-propan-2-yl-4-[(4-propan-2-yloxyphenyl ) methyl] pyrazol -3-yl] oxyoxan-2-yl] methylcarbonate;GSK189075;ethyl(((2R,3S,4S,5R,6S)-6-((4-(4-isopropoxybenzyl)-1-isopropyl-5-methyl- 1H-pyraChemic albookzol-3-yl)oxy)-3,4,5-tri(l1-oxidanyl) tetrahydro-2H-pyran-2-yl)methyl)carbonateGSK-189075;EOS-61714; UAOCLDQAQNNEAX-ABMICEGHSA- N;β-D-Glucopyranoside,5-methyl-4-[[4-(1-methylethoxy)methyl]-1-(1-methylethylum)-1H-pyrazolum-3-yl,6-(ethylcarbonatum); GSK189075A
copyRight
M CAS # 59-02-9, Vitamin E, D-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
Formulae hypotheticae C26H38N2O9
M. Pondus 522.6
CAS Subcriptio Number 442201-24-3


Pertractatio et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum



Hot Tags: Remogliflozin etabonate, China, Suppliers, Manufacturers, Factory
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept